![Correlation between psoriasis area severity index score and metabolic syndrome in psoriatic patients in Menoufia University Mohaseb AI, El-Farargy SM, Yasien HA, Ghanayem NM - Menoufia Med J Correlation between psoriasis area severity index score and metabolic syndrome in psoriatic patients in Menoufia University Mohaseb AI, El-Farargy SM, Yasien HA, Ghanayem NM - Menoufia Med J](https://www.mmj.eg.net/articles/2021/34/3/images/MenoufiaMedJ_2021_34_3_896_328337_t6.jpg)
Correlation between psoriasis area severity index score and metabolic syndrome in psoriatic patients in Menoufia University Mohaseb AI, El-Farargy SM, Yasien HA, Ghanayem NM - Menoufia Med J
![POCKET.MD - Psoriasis Severity Calculator, PASI(Psoriasis Area Severity Index) is a measure of overall psoriasis severity and coverage, and BS... POCKET.MD - Psoriasis Severity Calculator, PASI(Psoriasis Area Severity Index) is a measure of overall psoriasis severity and coverage, and BS...](http://www.pocket.md/images/appImages/screenshots/1384596010.jpeg)
POCKET.MD - Psoriasis Severity Calculator, PASI(Psoriasis Area Severity Index) is a measure of overall psoriasis severity and coverage, and BS...
![PASI vs PO‐PASI: Patient‐Oriented PASI (PO‐PASI) is comparable to clinician score PASI - Montes de Oca Pedrosa - 2022 - Australasian Journal of Dermatology - Wiley Online Library PASI vs PO‐PASI: Patient‐Oriented PASI (PO‐PASI) is comparable to clinician score PASI - Montes de Oca Pedrosa - 2022 - Australasian Journal of Dermatology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/5e273e28-94f9-4a61-be41-3d02ba8af628/ajd13738-tbl-0001-m.jpg)
PASI vs PO‐PASI: Patient‐Oriented PASI (PO‐PASI) is comparable to clinician score PASI - Montes de Oca Pedrosa - 2022 - Australasian Journal of Dermatology - Wiley Online Library
![Early Treatment Targets for Predicting Long-term Dermatology Life Quality Index Response in Patients with Moderate-to-Severe Plaque Psoriasis: A Post-hoc Analysis from a Long-term Clinical Study – JCAD | The Journal of Clinical Early Treatment Targets for Predicting Long-term Dermatology Life Quality Index Response in Patients with Moderate-to-Severe Plaque Psoriasis: A Post-hoc Analysis from a Long-term Clinical Study – JCAD | The Journal of Clinical](https://jcadonline.com/wp-content/uploads/September2020BurgeTable1.jpg)
Early Treatment Targets for Predicting Long-term Dermatology Life Quality Index Response in Patients with Moderate-to-Severe Plaque Psoriasis: A Post-hoc Analysis from a Long-term Clinical Study – JCAD | The Journal of Clinical
![Table 3 from Assessing psoriasis severity and outcomes for clinical trials and routine clinical practice. | Semantic Scholar Table 3 from Assessing psoriasis severity and outcomes for clinical trials and routine clinical practice. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/5b5fe1753c6637c3d8d05d3474c75480496dc8b7/8-Table3-1.png)
Table 3 from Assessing psoriasis severity and outcomes for clinical trials and routine clinical practice. | Semantic Scholar
![Predicting Psoriasis Area Severity Index (PASI) using decision tree classifier - Mohammadreza's Homepage Predicting Psoriasis Area Severity Index (PASI) using decision tree classifier - Mohammadreza's Homepage](https://mohammadrezaazimi.github.io/images/PASI/table.png)
Predicting Psoriasis Area Severity Index (PASI) using decision tree classifier - Mohammadreza's Homepage
![Life | Free Full-Text | Psoriasis Management Challenges Regarding Difficult-to-Treat Areas: Therapeutic Decision and Effectiveness Life | Free Full-Text | Psoriasis Management Challenges Regarding Difficult-to-Treat Areas: Therapeutic Decision and Effectiveness](https://pub.mdpi-res.com/life/life-12-02050/article_deploy/html/images/life-12-02050-g001.png?1670482868)
Life | Free Full-Text | Psoriasis Management Challenges Regarding Difficult-to-Treat Areas: Therapeutic Decision and Effectiveness
![Analysis of Body Regions and Components of PASI Scores During Adalimumab or Methotrexate Treatment for Patients With Moderate-to-Severe Psoriasis - JDDonline - Journal of Drugs in Dermatology Analysis of Body Regions and Components of PASI Scores During Adalimumab or Methotrexate Treatment for Patients With Moderate-to-Severe Psoriasis - JDDonline - Journal of Drugs in Dermatology](http://dl.jddonline.com/articleimages/article_2456/table1.png)
Analysis of Body Regions and Components of PASI Scores During Adalimumab or Methotrexate Treatment for Patients With Moderate-to-Severe Psoriasis - JDDonline - Journal of Drugs in Dermatology
![Figure 1 from Assessing psoriasis severity and outcomes for clinical trials and routine clinical practice. | Semantic Scholar Figure 1 from Assessing psoriasis severity and outcomes for clinical trials and routine clinical practice. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/5b5fe1753c6637c3d8d05d3474c75480496dc8b7/7-Figure1-1.png)